MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited EBITDA per Share 2011-2026 | BNR
Annual EBITDA per Share Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | -4.62 | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.62 | -4.62 | -4.62 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 117.7 | 2.28 % | $ 35.8 B |  USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 16.76 | 4.42 % | $ 893 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.2 | -4.35 % | $ 9.73 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.43 | 4.38 % | $ 1.9 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 23.18 | 0.22 % | $ 644 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 177.87 | 1.25 % | $ 8.82 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 498.89 | 1.09 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 194.47 | 2.58 % | $ 139 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.59 | 5.4 % | $ 425 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 7.95 | 3.38 % | $ 1.02 B | USA |
 |
Illumina
ILMN
|
-3.01 | $ 126.18 | 4.34 % | $ 20.1 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 15.34 | 6.31 % | $ 464 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 80.98 | 3.03 % | $ 10.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.69 | 0.15 % | $ 279 M | USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.77 | 2.79 % | $ 89.9 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.07 | -3.05 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.52 | 0.76 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 110.04 | 3.02 % | $ 9.08 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.64 | 0.01 % | $ 2.68 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 263.77 | 1.09 % | $ 21.9 B | USA |
 |
Natera
NTRA
|
-5.33 | $ 199.3 | 3.25 % | $ 19.6 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 119.06 | 1.64 % | $ 5.57 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 80.85 | 0.32 % | $ 5.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neuronetics
STIM
|
-0.42 | $ 1.37 | 1.11 % | $ 90.4 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 190.84 | -0.36 % | $ 21.2 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.32 | -1.01 % | $ 2.02 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 4.97 | 0.61 % | $ 3.91 M | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |